Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells

Apoptosis

Volumn 16, Issue 10, 2011, Pages 1042-1053

  Kauntz, Henriette ^a   Bousserouel, Souad ^a   Gossé, Francine ^a   Raul, Francis ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Apoptosis; Autophagy; Colon cancer; Flavono? ; Mitochondria; TRAIL

Indexed keywords

CASPASE 10; CASPASE 3; CASPASE 8; CASPASE 9; DEATH RECEPTOR 5; PROTEIN BID; SILIBININ;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER CELL CULTURE; CANCER SURVIVAL; CELL DEATH; CELL SURFACE; COLON ADENOCARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SILYBUM MARIANUM;

ADENOCARCINOMA; AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASE 10; CASPASE 3; CASPASE 8; CASPASES; CELL LINE, TUMOR; COLONIC NEOPLASMS; HUMANS; MACROLIDES; OLIGOPEPTIDES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SIGNAL TRANSDUCTION; SILYMARIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

SILYBUM MARIANUM;

EID: 82955187812     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-011-0631-z     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249. doi:10.3322/ caac.20006
2. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765-781. doi:10.1016/j.ejca.2009.12.014
3. Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P (2010) Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol Assess 14:1-206. doi:10.3310/hta14320
4. Naithani R, Huma LC, Moriarty RM, McCormick DL, Mehta RG (2008) Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials. Curr Med Chem 15:1044-1071 (Pubitemid 352005717)
5. Gupta SC, Kim JH, Prasad S, Aggarwal BB (2010) Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29:405-434. doi:10.1007/s10555-010-9235-2
6. West NJ, Courtney ED, Poullis AP, Leicester RJ (2009) Apoptosis in the colonic crypt, colorectal adenomata, and manipulation by chemoprevention. Cancer Epidemiol Biomark Prev 18:1680-1687. doi:10.1158/1055-9965.EPI-09-0006
7. Ghobrial IM, Witzig TE, Adjei AA (2005) Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55:178-194. doi: 10.3322/canjclin.55.3.178 (Pubitemid 40826487)
8. Yang SY, Sales KM, Fuller B, Seifalian AM, Winslet MC (2009) Apoptosis and colorectal cancer: implications for therapy. Trends Mol Med 15:225-233. doi:10.1016/j.molmed.2009.03.003
9. Opipari AW Jr, Tan L, Boitano AE, Sorenson DR, Aurora A, Liu JR (2004) Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 64:696-703. doi:10.1158/0008-5472.CAN-03-2404 (Pubitemid 38120912)
10. Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, Domingo D, Yahalom J (2001) A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 61:439-444 (Pubitemid 32128593)
11. Bijnsdorp IV, Peters GJ, Temmink OH, Fukushima M, Kruyt FA (2010) Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells. Int J Cancer 126:2457-2468. doi:10.1002/ijc.24943
12. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Selfeating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8:741-752. doi:10.1038/nrm2239 (Pubitemid 47312826)
13. Gazák R, WalterováD, Kren V (2007) Silybin and silymarin - new and emerging applications in medicine. Curr Med Chem 14:315-338
14. Singh RP, Agarwal R (2005) Mechanisms and preclinical efficacy of silibinin in preventing skin cancer. Eur J Cancer 41:1969-1979. doi:10.1016/j.ejca.2005.03.033 (Pubitemid 41557682)
15. Singh RP, Agarwal R (2006) Prostate cancer chemoprevention by silibinin: bench to bedside. Mol Carcinog 45(6):436-442. doi: 10.1002/mc.20223 (Pubitemid 43865852)
16. Tyagi A, Singh RP, Ramasamy K, Raina K, Redente EF, Dwyer- Nield LD, Radcliffe RA, Malkinson AM, Agarwal R (2009) Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3. Cancer Prev Res (Phila) 2:74-83. doi: 10.1158/1940-6207
17. Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal R (2003) Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22:8271-8282. doi:10.1038/sj.onc.1207158 (Pubitemid 37485520)
18. Kaur M, Velmurugan B, Tyagi A, Deep G, Katiyar S, Agarwal C, Agarwal R (2009) Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft. Mol Cancer Ther 8:2366-2374. doi: 10.1158/1535-7163.MCT-09-0304
19. Hogan FS, Krishnegowda NK, Mikhailova M, Kahlenberg MS (2007) Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer. J Surg Res 143:58-65. doi:10.1016/j.jss.2007.03.080 (Pubitemid 47562449)
20. Kaur M, Velmurugan B, Tyagi A, Agarwal C, Singh RP, AgarwalR (2010) Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling. Neoplasia 12:415-424. doi: 10.1593/neo.10188
21. Duan W, Jin X, Li Q, Tashiro S, Onodera S, Ikejima T (2010) Silibinin induced autophagic and apoptotic cell death in HT1080 cells through a reactive oxygen species pathway. J Pharmacol Sci 113:48-56. doi:10.1254/jphs.09315FP
22. Hewitt RE, McMarlin A, Kleiner D, Wersto R, Martin P, Tsokos M, Stamp GW, Stetler-StevensonWG(2000) Validation of a model of colon cancer progression. J Pathol 192:446-454. doi:10.1002/ 1096-9896(2000)9999:9999\:AID-PATH775[3.0.CO;2- K
23. Novo D, Perlmutter NG, Hunt RH, Shapiro HM (1999) Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique. Cytometry 35:55-63. doi:10.1002/(SICI)1097-0320 (Pubitemid 29031192)
24. Fischer B, Benzina S, Jeannequin P, Dufour P, Bergerat JP, Denis JM, Gueulette J, Bischoff PL (2005) Fast neutrons-induced apoptosis is Fas-independent in lymphoblastoid cells. Biochem Biophys Res Commun 334:533-542. doi:10.1016/j.bbrc.2005.06.125 (Pubitemid 40982399)
25. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real- time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408. doi:10.1006/meth.2001. 1262 (Pubitemid 34164012)
26. Riccardi C, Nicoletti I (2006) Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 1:1458-1461. doi: 10.1038/nprot.2006.238
27. Russo M, Mupo A, Spagnuolo C, Russo GL (2010) Exploring death receptor pathways as selective targets in cancer therapy. Biochem Pharmacol 80:674-682. doi:10.1016/j.bcp.2010.03.011
28. Milhas D, Cuvillier O, Therville N, ClavéP, Thomsen M, Levade T, Benoist H, Ségui B (2005) Caspase-10 triggers Bid cleavage and caspase cascade activation in FasL-induced apoptosis. J Biol Chem 280:19836-19842. doi:10.1074/jbc.M414358200 (Pubitemid 41379510)
29. Pan MH, Lai CS, Wu JC, Ho CT (2011) Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol Nutr Food Res 55:32-45. doi:10.1002/mnfr.201000412
30. CheungCW,Gibbons N, Johnson DW, Nicol DL (2010) Silibinin- a promising new treatment for cancer. Anticancer Agents Med Chem 10:186-195
31. Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, Harrison GS, Pierson AS, Agarwal R, GlodéLM (2007) A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Investig New Drugs 25(2):139-146. doi:10.1007/s10637-006-9019-2 (Pubitemid 46020872)
32. Flaig TW, GlodéM, Gustafson D, van Bokhoven A, Tao Y, Wilson S, Su LJ, Li Y, Harrison G, Agarwal R, Crawford ED, Lucia MS, Pollak M (2010) A study of high-dose oral silybinphytosome followed by prostatectomy in patients with localized prostate cancer. Prostate 70:848-855. doi:10.1002/pros.21118
33. Hoh C, Boocock D, Marczylo T, Singh R, Berry DP, Dennison AR, Hemingway D, Miller A, West K, Euden S, Garcea G, Farmer PB, Steward WP, Gescher AJ (2006) Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences. Clin Cancer Res 12:2944-2950. doi:10.1158/1078- 0432.CCR-05-2724
34. Gura T (1997) How TRAIL kills cancer cells, but not normal cells. Science 277:768. doi:10.1126/science.277.5327.768 (Pubitemid 27366709)
35. Kong CK, Lam WS, Chiu LC, Ooi VE, Sun SS, Wong YS (2009) A rice bran polyphenol, cycloartenyl ferulate, elicits apoptosis in human colorectal adenocarcinoma SW480 and sensitizes metastatic SW620 cells to TRAIL-induced apoptosis. Biochem Pharmacol 77:1487-1496. doi:10.1016/j.bcp.2009.02.008
36. Kim K, Fisher MJ, Xu SQ, El-Deiry WS (2000) Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin Cancer Res 6:335-346 (Pubitemid 30111448)
37. Simon HU, Haj-Yehia A, Levi-Schaffer F (2000) Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5:415-418. doi:10.1023/A: 1009616228304 (Pubitemid 32162623)
38. Chen Q, Chai YC, Mazumder S, Jiang C, Macklis RM, Chisolm GM, Almasan A (2003) The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction. Cell Death Differ 10:323-334. doi:10.1038/sj.cdd. 4401148 (Pubitemid 36582370)
39. Low IC, Chen ZX, Pervaiz S (2010) Bcl-2 modulates resveratrolinduced ROS production by regulating mitochondrial respiration in tumor cells. Antioxid Redox Signal 13:807-819. doi:10.1089/ars.2009.3050
40. De la Lastra CA, Villegas I (2007) Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 35:1156-1160. doi:10.1042/BST0351156 (Pubitemid 350206449)
41. GosséF, Roussi S, Guyot S, Schoenfelder A, Mann A, Bergerat JP, Seiler N, Raul F (2006) Potentiation of apple procyanidintriggered apoptosis by the polyamine oxidase inactivator MDL 72527 in human colon cancer-derived metastatic cells. Int J Oncol 29:423-428
42. Maldonado-Celis ME, Bousserouel S, GosséF, Minker C, Lobstein A, Raul F (2009) Differential induction of apoptosis by apple procyanidins in TRAIL-sensitive human colon tumor cells and derived TRAIL-resistant metastatic cells. J Cancer Mol 5:21-30. http://www.mupnet.com/JOCM%205(1)%2021.htm
43. Dalby KN, Tekedereli I, Lopez-Berestein G, Ozpolat B (2010) Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 6:322-329. doi: 10.4161/auto.6.3.1162
44. Choi CH, Jung YK, Oh SH (2010) Autophagy induction by capsaicin in malignant human breast cells is modulated by p38 and extracellular signal-regulated mitogen-activated protein kinases and retards cell death by suppressing endoplasmic reticulum stress-mediated apoptosis. Mol Pharmacol 78:114-125. doi: 10.1124/mol.110.063495